| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 81,791 | 82,627 | 90,727 | 82,684 | | Cost of Revenue | 63,739 | 29,400 | 73,031 | 50,755 | | | Gross Profit | 18,052 | 53,227 | 17,696 | 31,929 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,605 | 43,541 | 4,168 | 28,480 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,326 | 4,163 | 4,029 | 3,956 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,580 | 5,523 | 9,499 | (507) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 774 | 771 | (37) | 13 | | Earnings Before Interest And Taxes | (64) | 8,576 | 9,598 | 3,528 | | Interest Expense | 2,924 | 3,079 | 2,726 | 2,968 | | Income Before Tax | (2,988) | 5,497 | 6,872 | 560 | | Income Tax Expense | 2,091 | 2,149 | 4,309 | 565 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,659 | 5,497 | 6,872 | (5) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,200 | 5,497 | 6,872 | (5) | | Preferred Stock And Other Adjustments | (92) | (92) | (92) | (92) | | | Net Income Applicable To Common Shares | $6,108 | $5,405 | $6,780 | ($97) |
|
0.02% Nasdaq 
Income Statement
